U.S. flag

An official website of the United States government

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 43

1.
Evaluation of AR, AR-V7, and p160 family as biomarkers for prostate cancer: insights into the clinical significance and disease progression
Ruan Pimenta, Feres Camargo Malulf, Poliana Romão, Giovana Vilas Boas Caetano, Karina Serafim da Silva, Vitoria Ghazarian, Gabriel A. dos Santos, Vanessa Guimarães, Iran Amorim Silva, Juliana Alves de Camargo, Saulo Recuero, Bárbara V. Lima Aguiar Melão, Alberto Azoubel Antunes, Miguel Srougi, William Nahas, Katia R. M. Leite, Sabrina T. Reis
J Cancer Res Clin Oncol. 2024; 150(2): 70. Published online 2024 Feb 2. doi: 10.1007/s00432-023-05598-x
PMCID:
PMC10837222
ArticlePDF–1.4M
2.
Distinct mesenchymal cell states mediate prostate cancer progression
Hubert Pakula, Mohamed Omar, Ryan Carelli, Filippo Pederzoli, Giuseppe Nicolò Fanelli, Tania Pannellini, Fabio Socciarelli, Lucie Van Emmenis, Silvia Rodrigues, Caroline Fidalgo-Ribeiro, Pier Vitale Nuzzo, Nicholas J. Brady, Wikum Dinalankara, Madhavi Jere, Itzel Valencia, Christopher Saladino, Jason Stone, Caitlin Unkenholz, Richard Garner, Mohammad K. Alexanderani, Francesca Khani, Francisca Nunes de Almeida, Cory Abate-Shen, Matthew B. Greenblatt, David S. Rickman, Christopher E. Barbieri, Brian D. Robinson, Luigi Marchionni, Massimo Loda
Nat Commun. 2024; 15: 363. Published online 2024 Jan 8. doi: 10.1038/s41467-023-44210-1
PMCID:
PMC10774315
ArticlePDF–14M
3.
Circulating Tumour DNA Biomarkers Associated with Outcomes in Metastatic Prostate Cancer Treated with Lutetium-177-PSMA-617
Megan Crumbaker, Leonard D. Goldstein, David H. Murray, Jiang Tao, Sarennya Pathmanandavel, Nicky Boulter, Lalith Ratnayake, Anthony M. Joshua, Sarah Kummerfeld, Louise Emmett
Eur Urol Open Sci. 2023 Nov; 57: 30–36. Published online 2023 Sep 26. doi: 10.1016/j.euros.2023.08.007
PMCID:
PMC10658415
ArticlePDF–493K
4.
Timing of Early Salvage Therapy for Patients With Biochemical Relapse of Prostate Carcinoma
Soňa Argalácsová, Michal Vočka, Otakar Čapoun, Lukáš Lambert
Oncol Rev. 2023; 17: 10676. Published online 2023 Sep 13. doi: 10.3389/or.2023.10676
PMCID:
PMC10522833
ArticlePDF–642K
5.
Distinct mesenchymal cell states mediate prostate cancer progression
Hubert Pakula, Mohamed Omar, Ryan Carelli, Filippo Pederzoli, Giuseppe Nicolò Fanelli, Tania Pannellini, Lucie Van Emmenis, Silvia Rodrigues, Caroline Fidalgo-Ribeiro, Pier V. Nuzzo, Nicholas J. Brady, Madhavi Jere, Caitlin Unkenholz, Mohammad K. Alexanderani, Francesca Khani, Francisca Nunes de Almeida, Cory Abate-Shen, Matthew B Greenblatt, David S. Rickman, Christopher E. Barbieri, Brian D. Robinson, Luigi Marchionni, Massimo Loda
Version 1. bioRxiv. Preprint. 2023 Apr 1. doi: 10.1101/2023.03.29.534769
Published in:
Nat Commun. 2024; 15: 363.
PMCID:
PMC10081210
ArticlePDF–2.3M
6.
Complexities of Prostate Cancer
Sobia Wasim, Sang-Yoon Lee, Jaehong Kim
Int J Mol Sci. 2022 Nov; 23(22): 14257. Published online 2022 Nov 17. doi: 10.3390/ijms232214257
PMCID:
PMC9696501
ArticlePDF–851K
7.
Efficacy of PACE4 pharmacotherapy in JHU-LNCaP-SM preclinical model of androgen independent prostate cancer
Nawel Mekdad, Thi Minh Hue Tran, Roxane Desjardins, Anna Kwiatkowska, Frédéric Couture, Robert Day
Sci Rep. 2022; 12: 17489. Published online 2022 Oct 19. doi: 10.1038/s41598-022-21593-7
PMCID:
PMC9582213
ArticlePDF–2.3M
8.
The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates
Claudia Buhigas, Anne Y. Warren, Wing-Kit Leung, Hayley C. Whitaker, Hayley J. Luxton, Steve Hawkins, Jonathan Kay, Adam Butler, Yaobo Xu, Dan J. Woodcock, Sue Merson, Fiona M. Frame, Atef Sahli, Federico Abascal, CRUK-ICGC Prostate Cancer Group, Iñigo Martincorena, G. Steven Bova, Christopher S. Foster, Peter Campbell, Norman J. Maitland, David E. Neal, Charlie E. Massie, Andy G. Lynch, Rosalind A. Eeles, Colin S. Cooper, David C. Wedge, Daniel S. Brewer
Mol Cancer. 2022; 21: 183. Published online 2022 Sep 22. doi: 10.1186/s12943-022-01644-3
PMCID:
PMC9494848
ArticlePDF–1.8M
9.
Spatio-temporal analysis of prostate tumors in situ suggests pre-existence of treatment-resistant clones
Maja Marklund, Niklas Schultz, Stefanie Friedrich, Emelie Berglund, Firas Tarish, Anna Tanoglidi, Yao Liu, Ludvig Bergenstråhle, Andrew Erickson, Thomas Helleday, Alastair D. Lamb, Erik Sonnhammer, Joakim Lundeberg
Nat Commun. 2022; 13: 5475. Published online 2022 Sep 17. doi: 10.1038/s41467-022-33069-3
PMCID:
PMC9482614
ArticlePDF–6.1M
10.
Dynamic expression of SNAI2 in prostate cancer predicts tumor progression and drug sensitivity
Ying Z. Mazzu, YuRou Liao, Subhiksha Nandakumar, Martin Sjöström, Lina E. Jehane, Romina Ghale, Barani Govindarajan, Travis A. Gerke, Gwo‐Shu Mary Lee, Jian‐Hua Luo, Sreenivasa R. Chinni, Lorelei A. Mucci, Felix Y. Feng, Philip W. Kantoff
Mol Oncol. 2022 Jul; 16(13): 2451–2469. Published online 2022 Feb 11. doi: 10.1002/1878-0261.13140
PMCID:
PMC9251866
ArticlePDF–3.1M
11.
Differential Expression of E2F Transcription Factors and Their Functional and Prognostic Roles in Human Prostate Cancer
Zhaodong Han, Rujun Mo, Shanghua Cai, Yuanfa Feng, Zhenfeng Tang, Jianheng Ye, Ren Liu, Zhiduan Cai, Xuejin Zhu, Yulin Deng, Zhihao Zou, Yongding Wu, Zhouda Cai, Yuxiang Liang, Weide Zhong
Front Cell Dev Biol. 2022; 10: 831329. Published online 2022 Apr 21. doi: 10.3389/fcell.2022.831329
PMCID:
PMC9068940
ArticlePDF–5.6M
12.
ASCL1 activates neuronal stem cell-like lineage programming through remodeling of the chromatin landscape in prostate cancer
Shaghayegh Nouruzi, Dwaipayan Ganguli, Nakisa Tabrizian, Maxim Kobelev, Olena Sivak, Takeshi Namekawa, Daksh Thaper, Sylvan C. Baca, Matthew L. Freedman, Adeleke Aguda, Alastair Davies, Amina Zoubeidi
Nat Commun. 2022; 13: 2282. Published online 2022 Apr 27. doi: 10.1038/s41467-022-29963-5
PMCID:
PMC9046280
ArticlePDF–4.0M
13.
Red Blood Cell Distribution Width Is Associated with All-cause Mortality but Not Adverse Cancer-specific Outcomes in Men with Clinically Localized Prostate Cancer Treated with Radical Prostatectomy: Findings Based on a Multicenter Shared Equal Access Regional Cancer Hospital Registry
Hazem Orabi, Lauren Howard, Christopher L. Amling, William J. Aronson, Matthew R. Cooperberg, Christopher J. Kane, Martha K. Terris, Zachary Klaassen, Jessica L. Janes, Stephen J. Freedland, Thomas J. Polascik
Eur Urol Open Sci. 2022 Mar; 37: 106–112. Published online 2022 Feb 10. doi: 10.1016/j.euros.2022.01.003
PMCID:
PMC8883186
ArticlePDF–783K
14.
The Effects of Statins on Prostate Cancer Patients Receiving Androgen Deprivation Therapy or Definitive Therapy: A Systematic Review and Meta-Analysis
Yu-Chen Hou, Yu-Hsuan Shao
Pharmaceuticals (Basel) 2022 Feb; 15(2): 131. Published online 2022 Jan 22. doi: 10.3390/ph15020131
PMCID:
PMC8875347
ArticlePDF–1.6M
15.
SATB1, genomic instability and Gleason grading constitute a novel risk score for prostate cancer
Christoph Dumke, Timo Gemoll, Martina Oberländer, Sandra Freitag-Wolf, Christoph Thorns, Axel Glaessgen, Rinse Klooster, Silvère M. van der Maarel, Jerker Widengren, Christian Doehn, Gert Auer, Jens K. Habermann
Sci Rep. 2021; 11: 24446. Published online 2021 Dec 27. doi: 10.1038/s41598-021-03702-0
PMCID:
PMC8712510
ArticlePDF–1.4M
16.
Establishment and characterization of prostate organoids from treatment-naïve patients with prostate cancer
Katia Cheaito, Hisham F. Bahmad, Ola Hadadeh, Hiba Msheik, Alissar Monzer, Farah Ballout, Christelle Dagher, Talar Telvizian, Nour Saheb, Ayman Tawil, Marwan El-Sabban, Albert El-Hajj, Deborah Mukherji, Mohamed Al-Sayegh, Wassim Abou-Kheir
Oncol Lett. 2022 Jan; 23(1): 6. Published online 2021 Nov 5. doi: 10.3892/ol.2021.13124
PMCID:
PMC8607232
ArticlePDF–5.5M
17.
Alternative splicing of NF-YA promotes prostate cancer aggressiveness and represents a new molecular marker for clinical stratification of patients
Silvia Belluti, Valentina Semeghini, Giovanna Rigillo, Mirko Ronzio, Daniela Benati, Federica Torricelli, Luca Reggiani Bonetti, Gianluca Carnevale, Giulia Grisendi, Alessia Ciarrocchi, Massimo Dominici, Alessandra Recchia, Diletta Dolfini, Carol Imbriano
J Exp Clin Cancer Res. 2021; 40: 362. Published online 2021 Nov 15. doi: 10.1186/s13046-021-02166-4
PMCID:
PMC8594157
ArticlePDF–11M
18.
Low endogenous testosterone levels are associated with the extend of lymphnodal invasion at radical prostatectomy and extended pelvic lymph node dissection
Antonio Benito Porcaro, Clara Cerrato, Alessandro Tafuri, Alberto Bianchi, Sebastian Gallina, Rossella Orlando, Nelia Amigoni, Riccardo Rizzetto, Alessandra Gozzo, Filippo Migliorini, Stefano Zecchini Antoniolli, Carmelo Monaco, Matteo Brunelli, Maria Angela Cerruto, Alessandro Antonelli
Int Urol Nephrol. 2021; 53(10): 2027–2039. Published online 2021 Jul 6. doi: 10.1007/s11255-021-02938-z
PMCID:
PMC8463355
ArticlePDF–1.2M
19.
HO-1 Modulates Aerobic Glycolysis through LDH in Prostate Cancer Cells
Florencia Cascardo, Nicolás Anselmino, Alejandra Páez, Estefanía Labanca, Pablo Sanchis, Valeria Antico-Arciuch, Nora Navone, Geraldine Gueron, Elba Vázquez, Javier Cotignola
Antioxidants (Basel) 2021 Jun; 10(6): 966. Published online 2021 Jun 16. doi: 10.3390/antiox10060966
PMCID:
PMC8235201
ArticlePDF–5.8M
20.
Identification of potential autophagy-associated lncRNA in prostate cancer
Jun Li, Hong Du, Wenqiang Chen, Mingxing Qiu, Peng He, Zhiwei Ma
Aging (Albany NY) 2021 May 15; 13(9): 13153–13165. Published online 2021 May 10. doi: 10.18632/aging.202997
PMCID:
PMC8148478
ArticlePDF–1.5M

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Filter your results:

Find related data

Recent activity

Clear Turn Off Turn On

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...
You are here: NCBI > Literature > PubMed Central (PMC)
Support Center